IRLA — IRulya Therapeutics Share News
0.000.00%
Last trade - 00:00- $355.93m
- $383.76m
Brief: Quince Therapeutics - Appoints Brigette Roberts As CEO Effective October 8, 2026
Quince Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Quince Therapeutics Reports Second Quarter 2026 Financial Results And Corporate Update
Quince Therapeutics Q2 net loss widens on acquisition charges
Quince Therapeutics, Inc. expected to post a loss of $17.88 a share - Earnings Preview
Brief: Quince Therapeutics - Offers 15,470,099 Shares Of Common Stock For Resale - SEC Filing
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Quince Announces Acquisition Of Orphai And Up To $187 Million Private Placement To Advance Pulmonary Pipeline
NASDAQ RESUMED AT 09:39 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:33 AM
Brief: Alphabet Reports Stake In PayPay And CME Group, Dissolves In Dexcom
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Quince Therapeutics Settles EIB Loan Obligations For $5.5 Mln
Brief: Quince Therapeutics Settles Approximately $16.4 Million Of Debt